InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dangerM post# 46301

Sunday, 02/03/2019 8:10:18 PM

Sunday, February 03, 2019 8:10:18 PM

Post# of 48316
Good points Danger. That 20% instead of 30% bar is very likely to get Oncosec a PISCES approval if they come in at around 24% BORR....although I think it will move up to the 30% or higher range with time. Along the way we should expect preliminary data from TNBC to give Oncosec a share boost and market confidence that they are on the way to multiple fda approvals in time. Earlier partnering or buyout will be on the table....because it is a possibility at any time. Nobody knows what plans Merck has, but if Oncosec continues to produce convincing data as it matures you can bet Merck will be more likely to pull the trigger. If they did not have faith in Oncosec they would not be involved in yet another trial, which will make three trials going in combo with Oncosec....and then Head and Neck will make 4 when that gets under way. When Merck loses interest they cancel trials not increase them like they are doing with Oncosec.